Phenylguanidine

Phenylguanidine

SCHEMBL300643

N=C(N)Nc1ccccc1.O=C(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Phenylguanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.56
TSHR P16473 2/20 0.56
EPHX1 P07099 1/20 0.56
EPHX2 P34913 1/20 0.56
CDK9 P50750 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56
GAA P10253 2/20 0.55
MAPT P10636 1/20 0.55
GFER P55789 1/20 0.55
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 2/20 0.52
TYR P14679 1/20 0.52
TAS2R38 P59533 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
PLAU P00749 2/20 0.50
KDM1A O60341 1/20 0.50
F2 P00734 1/20 0.50
PLG P00747 1/20 0.50
PLAT P00750 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylguanidine SCHEMBL1950328 1.00 TP53 (0.56) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL8887604 0.98 TP53 (0.54) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL256023 0.93 ALDH1A1 (0.58) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL11154590 0.91 HSD17B10 (0.59) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL28414520 0.91 HSD17B10 (0.52) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL11092906 0.91 ALDH1A1 (0.56) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL29249611 0.91 ALDH1A1 (0.56) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL4027020 0.91 ALDH1A1 (0.56) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL28765733 0.87 HSD17B10 (0.48) TP53TSHREPHX1EPHX2CDK9
Phenylguanidine SCHEMBL10882671 0.86 MAPT (0.52) TP53TSHREPHX1EPHX2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119503795-A Modified activated carbon, silicon-carbon composite material, preparation method thereof, pole piece, application and electrochemical device 上海杉杉新材料有限公司 2025-02-25 CN claimed
CN-107879953-B Method and device for recycling phenylguanidine carbonate in wastewater 南通江山农药化工股份有限公司 2023-07-28 CN claimed
CN-112813061-A Pretreatment reagent for nucleic acid extraction of cat body fluid sample and nucleic acid extraction method 上海基灵生物科技有限公司 2021-05-18 CN claimed
CN-212293379-U Phenyl guanidine carbonate crystal particle form lifting device 南通江山农药化工股份有限公司 2021-01-05 CN claimed
CN-111747870-A Process and equipment for improving crystal particle form of phenylguanidine carbonate 南通江山农药化工股份有限公司 2020-10-09 CN claimed
CN-111518302-A Production formula and process of corrosion-aging-resistant insulating tape 浙江万叶绝缘材料有限公司 2020-08-11 CN claimed
CN-111362282-A Production method and system for recycling sodium chloride from phenylguanidine carbonate synthetic wastewater 利民化学有限责任公司 2020-07-03 CN claimed
CN-110690516-A Waste lead-acid storage battery recovery treatment process 骆驼集团(安徽)再生资源有限公司 2020-01-14 CN claimed
CN-109161208-A A kind of high fire-retardance corrosion proof cable material and preparation method thereof 曹佳男 2019-01-08 CN claimed
CN-207659355-U Phenyl guanidine carbonate recovery device in waste water 南通江山农药化工股份有限公司 2018-07-27 CN claimed
US-7279577-B2 Method for producing 2-anilino-4,6-dimethylpyrimidine DEGUSSA AG (DE) 2007-10-09 US claimed
US-20060127337-A1 Process for relaxing keratin fibres L'OREAL (FR) 2006-06-15 US claimed
US-20050154203-A1 Method for producing 2-anilino-4,6-dimethylpyrimidine ALZCHEM TROSTBERG GMBH (DE) 2005-07-14 US claimed
EP-1476436-A1 METHOD FOR PRODUCING 2-ANILINO-4,6-DIMETHYLPYRIMIDINE Degussa AG (DE) 2004-11-17 EP claimed
WO-2003070708-A1 METHOD FOR PRODUCING 2-ANILINO-4,6-DIMETHYLPYRIMIDINE DEGUSSA AG (DE) 2003-08-28 WO claimed
EP-0717038-B1 Process for the preparation of 2-anilino-pyramidine derivatives HOECHST SCHERING AGREVO GMBH (DE) 1998-11-18 EP claimed
EP-0717038-A1 Process for the preparation of 2-anilino-pyramidine derivatives Hoechst Schering AgrEvo GmbH (DE) 1996-06-19 EP claimed
EP-0560726-B1 Process for the production of guanidine derivatives CIBA GEIGY AG (CH) 1996-05-29 EP claimed
US-5276186-A Process for the production of guanidine derivatives CIBA-GEIGY CORPORATION (US) 1994-01-04 US claimed
EP-0560726-A2 Process for the production of guanidine derivatives CIBA-GEIGY AG (CH) 1993-09-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060127337-A1 Process for relaxing keratin fibres KRT18, TPM4, MYLK TP53 3884/4885TSHR 3657/4885EPHX1 4336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.